Dan Shu
University of Maryland, Baltimore(US)Harvard University(US)University of Electronic Science and Technology of China(CN)Dalian Institute of Chemical Physics(CN)Chinese Academy of Sciences(CN)Princeton Public Schools(US)McLean Hospital(US)Sichuan Agricultural University(CN)Institute of Catalysis and Petrochemistry(RU)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)BYD (China)(CN)Chengdu Institute of Biology(CN)Tongji Hospital(CN)Chemical Pharmaceutical Research Institute(BG)Wuhan University of Science and Technology(CN)Huazhong University of Science and Technology(CN)The Ohio State University(US)University of Baltimore(US)Wuhan Sports University(CN)Chongqing Medical University(CN)Taiyuan University of Technology(CN)
Publications by Year
Research Areas
Advanced biosensing and bioanalysis techniques, RNA Interference and Gene Delivery, RNA and protein synthesis mechanisms, Bacteriophages and microbial interactions, MicroRNA in disease regulation
Most-Cited Works
- → Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study(2020)1,396 cited
- → Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics(2011)435 cited
- → Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology(2015)270 cited
- → Stable RNA nanoparticles as potential new generation drugs for cancer therapy(2013)243 cited
- → Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers(2012)196 cited
- → Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology(2004)185 cited